Alpine Immune Sciences (NASDAQ: ALPN)
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-12-20 | ||||||
REV |
FY 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-11-09 | ||||||
REV |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Alpine Immune Sciences (NASDAQ: ALPN) through any online brokerage.
Other companies in Alpine Immune Sciences’s space includes: Macrogenics (NASDAQ:MGNX), AVEO Pharmaceuticals (NASDAQ:AVEO), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA) and Graphite Bio (NASDAQ:GRPH).
The latest price target for Alpine Immune Sciences (NASDAQ: ALPN) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting ALPN to fall to within 12 months (a possible -54.55% downside). 50 analyst firms have reported ratings in the last year.
The stock price for Alpine Immune Sciences (NASDAQ: ALPN) is $8.8 last updated August 12, 2022, 8:00 PM UTC.
The next Alpine Immune Sciences (ALPN) dividend date is projected to be Thursday, September 1, 2022.
Alpine Immune Sciences’s FY earnings are confirmed for Wednesday, December 20, 2023.
There is no upcoming split for Alpine Immune Sciences.
Alpine Immune Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.